SEC Form SC 13G filed by Paratek Pharmaceuticals Inc.
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO
RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Paratek Pharmaceuticals, Inc. |
(Name of Issuer) |
Common Stock, par value $0.001 per share |
(Title of Class of Securities) |
699374302 |
(CUSIP Number) |
December 31, 2021 |
(Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ |
Rule 13d-1(b) |
☒ |
Rule 13d-1(c) |
☐ |
Rule 13d-1(d) |
CUSIP No. 699374302
|
13G |
Page 2 of 11 |
1 |
NAME OF REPORTING PERSONS
NexPoint Real Estate Opportunities, LLC |
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ☐ |
3 |
SEC USE ONLY
|
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
NUMBER OF |
5 |
SOLE VOTING POWER 0 |
6 |
SHARED VOTING POWER 50,000 |
|
7 |
SOLE DISPOSITIVE POWER 0 |
|
8 |
SHARED DISPOSITIVE POWER 50,000 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
50,000 |
|
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |
☐ |
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.01% |
|
12 |
TYPE OF REPORTING PERSON*
OO |
CUSIP No. 699374302
|
13G |
Page 3 of 11 |
1 |
NAME OF REPORTING PERSONS
Drugcrafters, LP |
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ☐ |
3 |
SEC USE ONLY
|
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
NUMBER OF |
5 |
SOLE VOTING POWER 0 |
6 |
SHARED VOTING POWER 303,367 |
|
7 |
SOLE DISPOSITIVE POWER 0 |
|
8 |
SHARED DISPOSITIVE POWER 303,367 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
303,367 |
|
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |
☐ |
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.6% |
|
12 |
TYPE OF REPORTING PERSON
PN |
CUSIP No. 699374302
|
13G |
Page 4 of 11 |
1 |
NAME OF REPORTING PERSONS
Highland Small-Cap Equity Fund |
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ☐ |
3 |
SEC USE ONLY
|
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
Massachusetts |
NUMBER OF |
5 |
SOLE VOTING POWER 0 |
6 |
SHARED VOTING POWER 64,770 |
|
7 |
SOLE DISPOSITIVE POWER 0 |
|
8 |
SHARED DISPOSITIVE POWER 64,770 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
64,770 |
|
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |
☐ |
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.13% |
|
12 |
TYPE OF REPORTING PERSON
IV |
CUSIP No. 699374302
|
13G |
Page 5 of 11 |
1 |
NAME OF REPORTING PERSONS
The Dugaboy Investment Trust |
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ☐ |
3 |
SEC USE ONLY
|
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
NUMBER OF |
5 |
SOLE VOTING POWER 0 |
6 |
SHARED VOTING POWER 2,474,060 |
|
7 |
SOLE DISPOSITIVE POWER 0 |
|
8 |
SHARED DISPOSITIVE POWER 2,474,060 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,474,060 |
|
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |
☐ |
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
4.93% |
|
12 |
TYPE OF REPORTING PERSON
OO |
CUSIP No. 699374302
|
13G |
Page 6 of 11 |
1 |
NAME OF REPORTING PERSONS
James D. Dondero |
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ☐ |
3 |
SEC USE ONLY
|
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States |
NUMBER OF |
5 |
SOLE VOTING POWER 0 |
6 |
SHARED VOTING POWER 2,892,197 |
|
7 |
SOLE DISPOSITIVE POWER 0 |
|
8 |
SHARED DISPOSITIVE POWER 2,892,197 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,892,197 |
|
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |
☐ |
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.7% |
|
12 |
TYPE OF REPORTING PERSON
HC, IN |
CUSIP No. 699374302
|
13G |
Page 7 of 11 |
SCHEDULE 13G
This Schedule 13G (this “Filing”) is being filed on behalf of Drugcrafters, LP a Delaware limited partnership (“Drugcrafters”), The Dugaboy Investment Trust, a Delaware Trust (the “Trust”), Highland Small-Cap Equity Fund (“Highland”), a Massachusetts investment company, NexPoint Real Estate Opportunities, LLC (“NREO”), a Delaware limited liability company and James D. Dondero (collectively, the “Reporting Persons”).
Item 1(a) |
Name of Issuer. |
|
Paratek Pharmaceuticals, Inc. |
Item 1(b) |
Address of Issuer’s Principal Executive Offices. |
|
75 Park Plaza |
|
Boston, Massachusetts 02116 |
Item 2(a) |
Name of Person Filing. |
(1) |
Drugcrafters, LP |
(2) |
Highland Small-Cap Equity Fund |
(3) |
NexPoint Real Estate Opportunities, LLC |
(4) |
The Dugaboy Investment Trust |
(5) |
James D. Dondero |
Item 2(b) |
Address of Principal Business Office, or, if none, Residence. |
|
For all Filers: |
|
300 Crescent Court, Suite 700 |
|
Dallas, Texas 75201 |
Item 2(c) |
Citizenship or Place of Organization. |
(1) |
Drugcrafters, LP is a Delaware limited partnership |
(2) |
Highland Small-Cap Equity Fund is a Massachusetts investment company |
(3) |
NexPoint Real Estate Opportunities, LLC is a Delaware limited liability company |
(4) |
James D. Dondero is a United States citizen |
(5) |
The Dugaboy Investment Trust is a Delaware trust |
CUSIP No. 699374302
|
13G |
Page 8 of 11 |
Item 2(d) |
Title of Class of Securities. |
|
Common Stock, par value $0.001 per share |
Item 2(e) |
CUSIP Number. |
|
699374302 |
Item 3 |
Reporting Person. |
If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a:
(a) ☐ |
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). |
(b) ☐ |
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). |
(c) ☐ |
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). |
(d) ☒ |
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). |
(e) ☐ |
An investment advisor in accordance with §240.13d-1(b)(1)(ii)(E). |
(f) ☐ |
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F). |
(g) ☒ |
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G). |
(h) ☐ |
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). |
(i) ☐ |
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3). |
(j) ☐ |
Group, in accordance with §240.13d-1(b)(1)(ii)(J). |
Item 4 |
Ownership. |
(a) |
Amount beneficially owned: |
Drugcrafters, LP: 303,367 Highland Small-Cap Equity Fund: 64,770 NexPoint Real Estate Opportunities, LLC: 50,000 The Dugaboy Investment Trust: 2,474,060 James D. Dondero: 2,892,197 |
CUSIP No. 699374302
|
13G |
Page 9 of 11 |
(b) |
Percent of Class: |
Drugcrafters, LP: 0.6% Highland Small-Cap Equity Fund: 0.13% NexPoint Real Estate Opportunities, LLC: 0.1% The Dugaboy Investment Trust: 4.93% James D. Dondero: 5.7% |
(c) |
Number of shares as to which the person has: |
(i) |
Sole power to vote or to direct the vote: |
|
Drugcrafters, LP: 0 Highland Small-Cap Equity Fund: 0 NexPoint Real Estate Opportunities, LLC: 0 NexPoint Advisors, L.P.: 0 The Dugaboy Investment Trust: 0 James D. Dondero: 0 |
(ii) |
Shared power to vote or direct the vote: |
|
Drugcrafters, LP: 303,367 Highland Small-Cap Equity Fund: 64,770 NexPoint Real Estate Opportunities, LLC: 50,000 The Dugaboy Investment Trust: 2,474,060 James D. Dondero: 2,892,197 |
(iii) |
Sole power to dispose or to direct the disposition of: |
|
Drugcrafters, LP: 0 Highland Small-Cap Equity Fund: 0 NexPoint Real Estate Opportunities, LLC: 0 NexPoint Advisors, L.P.: 0 The Dugaboy Investment Trust: 0 James D. Dondero: 0 |
CUSIP No. 699374302
|
13G |
Page 10 of 11 |
(iv) |
Shared power to dispose or to direct the disposition of: |
|
Drugcrafters, LP: 303,367 Highland Small-Cap Equity Fund: 64,770 NexPoint Real Estate Opportunities, LLC: 50,000 The Dugaboy Investment Trust: 2,474,060 James D. Dondero: 2,892,197 |
Item 5 |
Ownership of Five Percent or Less of a Class. |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]
Item 6 |
Ownership of More Than Five Percent on Behalf of Another Person. |
Inapplicable.
Item 7 |
Identification and Classification of the Subsidiary which Acquired the Security Being Reported On by the Parent Holding Company. |
Inapplicable.
Item 8 |
Identification and Classification of Members of the Group. |
Inapplicable.
Item 9 |
Notice of Dissolution of Group. |
Inapplicable.
Item 10 |
Certification. |
By signing below each of the Reporting Persons certifies that, to the best of such person’s knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
CUSIP No. 699374302
|
13G |
Page 11 of 11 |
Exhibits |
Exhibit 99.1 |
|
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: March 11, 2022
DRUGCRAFTERS, LP |
|||
By: |
/s/ James D. Dondero |
||
Name: James D. Dondero |
|||
Title: Managing Member of the General Partner |
|||
HIGHLAND SMALL-CAP EQUITY FUND |
|||
By: |
/s/ Frank Waterhouse |
||
Name: Frank Waterhouse |
|||
Title: Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer and Treasurer |
|||
NexPoint Real Estate Opportunities, LLC |
|||
By: |
/s/ Brian Mitts |
||
Name: Brian Mitts |
|||
Title: Authorized Signatory |
|||
THE DUGABOY INVESTMENT TRUST | |||
By: | /s/ Nancy Dondero | ||
Name: Nancy Dondero | |||
Title: Trustee |
/s/ James D. Dondero |
||
James D. Dondero |